| Female Reproductive System Endometrioid Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived49 of 49show fewer |
|---|
| → investigated in trials for | Paclitaxelsmall molecule 30 trials (11 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Megestrolsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-VEGF Monoclonal Antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Female Reproductive System Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |